Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vistagen Therapeutics, Inc. - Common Stock (NQ: VTGN ) 2.590 -0.010 (-0.38%) Streaming Delayed Price Updated: 10:13 AM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 48,903 Open 2.590 Bid (Size) 2.580 (7) Ask (Size) 2.600 (5) Prev. Close 2.600 Today's Range 2.540 - 2.690 52wk Range 2.220 - 5.860 Shares Outstanding 9,362,444 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vistagen to Present at the Stifel 2024 Healthcare Conference November 14, 2024 From Vistagen Via Business Wire Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update November 07, 2024 From Vistagen Via Business Wire Performance YTD -49.71% -49.71% 1 Month -0.38% -0.38% 3 Month -13.67% -13.67% 6 Month -25.57% -25.57% 1 Year -49.61% -49.61% More News Read More Vistagen to Present at the 2024 Neuroscience Education Institute Congress November 05, 2024 From Vistagen Via Business Wire Vistagen to Report Fiscal Year 2025 Second Quarter Results and Host Corporate Update Conference Call on November 7, 2024 November 01, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Announces Joint Ceremony to Ring Nasdaq Closing Bell in Honor of World Mental Health Day October 09, 2024 Via Investor Brand Network Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day October 09, 2024 From Vistagen Via Business Wire Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder September 23, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report August 14, 2024 Via Investor Brand Network VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025 August 13, 2024 Via InvestorPlace Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update August 13, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call August 06, 2024 Via Investor Brand Network Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024 August 06, 2024 From Vistagen Via Business Wire 3 Stocks Under $15 That Could Make You a Millionaire July 26, 2024 Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio July 09, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine July 09, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor June 27, 2024 Via Investor Brand Network Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year June 27, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2024 Financial Report, Corporate Update June 12, 2024 Via Investor Brand Network VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 June 12, 2024 Via InvestorPlace Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update June 11, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules FY 2024 Financial Results Report, Conference Call June 07, 2024 Via Investor Brand Network Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024 June 07, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) CEO to Present at Jefferies Global Healthcare Conference May 29, 2024 Via Investor Brand Network Vistagen to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present Posters at Upcoming ASCP Conference May 23, 2024 Via Investor Brand Network Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
